4//SEC Filing
ARCA biopharma, Inc. 4
Accession 0001209191-13-044975
$ORKACIK 0000907654operating
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 8:56 PM ET
Size
7.3 KB
Accession
0001209191-13-044975
Insider Transaction Report
Form 4
Ozeroff Christopher David
EVP & General Counsel
Transactions
- Award
Common Stock
2013-09-17$1.38/sh+75,000$103,500→ 92,537 total - Award
Stock Option (right to buy)
2013-09-17+42,642→ 42,642 totalExercise: $1.38Exp: 2023-09-17→ Common Stock (42,642 underlying)
Footnotes (2)
- [F1]Represents shares issued as restricted stock units (an "RSU") under the Issuer's 2013 Equity Incentive Plan (the "Plan"). The RSUs vest in three equal annual installments from the date of grant, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan prior to such time.
- [F2]Grant to the Reporting Person of a stock option under the 2013 Equity Incentive Plan, vesting in 36 equal monthly installments from the date of grant, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan prior to such time.
Documents
Issuer
ARCA biopharma, Inc.
CIK 0000907654
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000907654
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 8:56 PM ET
- Size
- 7.3 KB